NEDD4 and melanoma: Quirit et al. (178) aiming to inhibit the proliferation of human melanoma cells, performed in silico binding simulations with the crystallographic structure of NEDD4-1, showing that each of the indolecarbinol compounds bound to the catalytic HECT domain purified from NEDD4-1 (178).